P2288The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy

2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
K Tsuchida ◽  
K Nishida ◽  
K Tanaka ◽  
T Akiyama ◽  
T Hakamata ◽  
...  
2020 ◽  
Vol 16 (2) ◽  
pp. e164-e172 ◽  
Author(s):  
Tomoya Hoshi ◽  
Akira Sato ◽  
Daigo Hiraya ◽  
Hiroaki Watabe ◽  
Noriyuki Takeyasu ◽  
...  

2013 ◽  
Vol 29 (3) ◽  
pp. 193-199 ◽  
Author(s):  
Yoshinari Enomoto ◽  
Raisuke Iijima ◽  
Masahide Tokue ◽  
Naoshi Ito ◽  
Yoshinori Nagashima ◽  
...  

2013 ◽  
Vol 37 (5) ◽  
pp. 463-466 ◽  
Author(s):  
Kazunori Toyoda ◽  
◽  
Masahiro Yasaka ◽  
Shinichiro Uchiyama ◽  
Kazunori Iwade ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Gregory Piazza ◽  
Shelley Hurwitz ◽  
Brett Carroll ◽  
Samuel Z Goldhaber

Introduction: A perceived increased risk of bleeding is one of the most frequent reasons for failure to prescribe anticoagulation for stroke prevention in atrial fibrillation (AF). We previously conducted a randomized controlled trial of alert-based computerized decision support (CDS) to increase prescription of antithrombotic therapy in 458 high-risk hospitalized patients with AF who were not being anticoagulated. Hypothesis: We hypothesized that patients with a perceived high risk for bleeding would have a similar HAS-BLED score and rate of major and clinically-relevant non-major bleeding. Methods: To determine the clinical characteristics and outcomes of these patients determined to be high-risk for bleeding, we analyzed the 248 patients in the alert group. Results: A perceived high risk of bleeding was the most common reason (77%) for omitting antithrombotic therapy. Median HAS-BLED scores were similar in these patients compared with those who were not deemed to have an increased bleeding risk (3 vs. 3, p=0.44). Despite being categorized as too high-risk for bleeding to receive antithrombotic therapy for stroke prevention at the time of the alert, nearly 12% of these patients were ultimately prescribed anticoagulation over the ensuing 90 days. The frequency of major and clinically-relevant non-major bleeding was similar between the two groups. Conclusions: In conclusion, a perceived high risk of bleeding was the most common reason for failure to prescribe antithrombotic therapy after the CDS alert. History of a prior bleeding event or underlying bleeding disorder was not reflected in a higher HAS-BLED score. Implementation of an alert-based CDS with specific attention to assessment of bleeding risk and mitigation warrants further study to encourage adherence to evidence-based clinical practice guideline recommendations for stroke prevention in AF.


Circulation ◽  
2019 ◽  
Vol 139 (6) ◽  
pp. 775-786 ◽  
Author(s):  
Nienke van Rein ◽  
Uffe Heide-Jørgensen ◽  
Willem M. Lijfering ◽  
Olaf M. Dekkers ◽  
Henrik T. Sørensen ◽  
...  

2017 ◽  
Vol 6 (1) ◽  
pp. 91-117 ◽  
Author(s):  
Mikhail S. Dzeshka ◽  
Richard A. Brown ◽  
Davide Capodanno ◽  
Gregory Y.H. Lip

Sign in / Sign up

Export Citation Format

Share Document